25

Nov2015
PDCI has developed considerable expertise assisting manufacturers with product listing agreements(PLAs) through the pan-Canadian Pharmaceutical Alliance (pCPA), with individual provinces (including Quebec) and with private payers.  With the formalization of the pCPA process and private payers moving aggressively into the PLA environment (see PDCIs white paper), PDCI is growing ... Read More

03

Nov2015
On Friday, October 30, 2015 PDCI presented a webinar entitled “Market Access Climate Change: the Evolving Impact of Product Listing Agreements”. The purpose of this webinar was to: Shed light on the recent developments at the pCPA; and Enhance the understanding of the growing practice of PLA negotiations in the private payer ... Read More

20

Oct2015
Interested in learning more about new developments at the pan-Canadian Pharmaceutical Alliance (pCPA)? Curious to know more about private payer Product Listing Agreements (PLAs) in Canada? PDCI Market Access (PDCI) is hosting a free webinar on Friday, October 30, 2015 from 11:00 AM -12:00 PM EDT titled Market Access Climate Change: the ... Read More

16

Oct2015
In a recent update released on their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced two significant developments: Québec is now participating in the pCPA; and The Office of the pCPA (the Office) is now operational. In Fall 2014, the Provincial/Territorial Health Ministers announced intentions for Québec’s participation in the Federation’s Health Care ... Read More

23

Feb2015
Effective February 9, 2015 and until this process is transitioned to the pan-Canadian Pharmaceutical Alliance (pCPA) office, Saskatchewan will serve as the single point of entry for the pan-Canadian generic price tier confirmation process. The Saskatchewan Drug Plan will verify that the Tiered Pricing Framework applies to the ... Read More

09

Feb2015
PDCI Market Access Inc. interviewed a representative from one of the pan-Canadian Pharmaceutical Alliance (pCPA) lead provinces and has produced an article providing guidance for negotiating with the pCPA. The pCPA has completed approximately 50 negotiations since it was established in 2010, but stakeholders are still looking for greater transparency ... Read More

16

Oct2014
Pan-Canadian Pharmaceutical Alliance (pCPA) has posted the IBM Report on its website  The much anticipated IBM report (entitled “Pan Canadian Drugs Negotiation Report”) has now been posted on the pCPA website. The objectives of the IBM engagement include: Recommending options for the development of a permanent model that will facilitate negotiations for brand ... Read More

07

Oct2014
PDCI Market Access has completed its benchmarking survey on the pan-Canadian Pharmaceutical Alliance (PCPA).  We received responses from manufacturers of 7 products that have successfully navigated this important reimbursement process.  The purpose of the survey was to gain a better understanding of the PCPA experience from the company perspective. The survey ... Read More